Kiromic Biopharma, Inc. Debt Conversion, Original Debt, Amount
Kiromic Biopharma, Inc. had Debt Conversion, Original Debt, Amount of $34.00 million as of 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2025-02-14
- 2024-12-31: Debt Conversion, Original Debt, Amount $34.00M.
| Period end | Debt Conversion, Original Debt, Amount |
|---|---|
| 2024-12-31 | $34.00M 10-K · filed 2025-02-14 |